Advanced Micro Devices Inc. (AMD) is set to report third quarter 2018 earnings results on Wednesday, October 24. The company’s revenues are expected to grow 4.1% to $1.71 billion while earnings are expected to increase 37.5% to $0.11. Over the past four quarters, AMD has managed to top expectations and it is expected to do so for the third quarter as well.
In the second quarter, AMD reported better-than-expected revenue and earnings. Revenues increased 53% to $1.76 billion while adjusted earnings totaled $0.14 per share. The Computing and Graphics segment saw a solid 64% revenue growth, boosted by strong demand for the Radeon and Ryzen products. The Ryzen along with the new Threadripper products are expected to push growth in the third quarter as well as future quarters.
Last quarter, the Embedded and Semi-Custom segment revenue grew 37% helped by higher sales of semi-custom and server products. The company’s 7nm (nanometers) processors will be capable of providing better power efficiency and the addition of new features like Secure Encrypted Virtualization (SEV) will give AMD’s products a significant competitive advantage.
AMD defies crypto blues; stock jumps as Q2 results beat street view
The semiconductor industry is expected to see benefits from the increasing prominence of artificial intelligence and this is likely to bode well for AMD as well. AMD and its new range of products are capable of giving tough competition to Intel (INTC).
Related: AMD Q2 2018 Earnings Transcript
AMD’s shares have soared 143% so far this year and looking at the past three months, the stock is up 52%. If the company meets expectations for the third quarter, the stock is likely to get a lift but if it misses, the stock is likely to see a drop. The overall sentiment around the stock is positive.
AMD’s competitors Intel and NVIDIA (NVDA) are expected to report their third quarter results on October 25 and November 15 respectively.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
